These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


255 related items for PubMed ID: 8371586

  • 41. [Prognosis of children with chronic myeloid leukemia: a retrospective analysis of 75 patients].
    Creutzig U, Ritter J, Zimmermann M, Klingebiel T.
    Klin Padiatr; 1996; 208(4):236-41. PubMed ID: 8926689
    [Abstract] [Full Text] [Related]

  • 42. [Causes of death in chronic myeloid leukemia. Analysis of 109 patients].
    Cervantes F, Sanz C, Bosch F, Rozman C.
    Sangre (Barc); 1991 Jun; 36(3):183-6. PubMed ID: 1948535
    [Abstract] [Full Text] [Related]

  • 43. CD7+ TdT+ chronic myelogenous leukemia blast crisis with null genotype.
    Smith MR, Mohamed AN, Karanes C.
    Leukemia; 1993 Feb; 7(2):177-80. PubMed ID: 7678877
    [Abstract] [Full Text] [Related]

  • 44. Immunophenotypic analysis of various blastic crises in chronic myeloid leukemia: correlations between CD7 expression and response to chemotherapy.
    Hirose Y, Masaki Y, Shimoyama K, Fukushima T, Kawabata H, Ogawa N, Wano Y, Sugai S.
    Int J Hematol; 2003 May; 77(4):420-2. PubMed ID: 12774936
    [No Abstract] [Full Text] [Related]

  • 45. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS, Lee YS, Yun YS, Kim YR, Jeong SS, Lee YK, She CJ, Yoon SS, Shin HR, Kim Y, Cho HI.
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [Abstract] [Full Text] [Related]

  • 46. JAK2V617F mutation in chronic myeloid leukemia predicts early disease progression.
    Pahore ZA, Shamsi TS, Taj M, Farzana T, Ansari SH, Nadeem M, Ahmad M, Naz A.
    J Coll Physicians Surg Pak; 2011 Aug; 21(8):472-5. PubMed ID: 21798133
    [Abstract] [Full Text] [Related]

  • 47. CD33, CD4-double positive blastic transformation in a patient with chronic myelogenous leukemia.
    Hirayama Y, Kohgo Y, Kanisawa Y, Fujii S, Ikeda K, Matsunaga T, Ito Y, Sakamaki S, Niitsu Y.
    Int J Hematol; 1993 Jun; 57(3):265-8. PubMed ID: 8364189
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. [Blast crisis of chronic myelogenous leukemia with blasts expressing both immature B lymphocyte- and myelomonocyte-associated antigens and differentiating into basophils in vitro].
    Utsunomiya Y, Iwamasa K, Yasukawa M, Tamai T, Shiosaka T, Bando S.
    Rinsho Ketsueki; 1990 Jul; 31(7):1017-21. PubMed ID: 2214182
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Enzyme negative blastic transformation of chronic myeloproliferative disorders: immunophenotyping of the blastic cell population.
    Matolcsy A, Izer I, Magyarlaki T, Baranyay F.
    Haematologia (Budap); 1991 Jul; 24(1):27-37. PubMed ID: 1813360
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
    Okabe M.
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.